Autoinflammatory Diseases 26.3.2015



Similar documents
Auto-inflammatory Syndromes Questions and Answers. Dr. med. Bruno Strebel

Biologic Treatments for Rheumatoid Arthritis

Inflammasomes and autoimmune diseases

Autoimmunity and immunemediated. FOCiS. Lecture outline

:: Familial Mediterranean fever

Autoinflammatory diseases in pediatrics

Treatment of Rheumatoid Arthritis in the New Millennium. Neal I. Shparago, D.O., FACP, FACR

Immune Modulating Drugs Prior Authorization Request Form

Systemic Juvenile Adiopathic Arthritis: Treatment Options 15. Alexei A. Grom, MD Cincinnati Children s Hospital Medical Center

Rheumatic Diseases, Psoriasis, and Crohn s Disease

Anti-inflammatory Agents: Present and Future

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

PATHOPHYSIOLOGY OF GOUT

Current Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists

PPAR-γ agonist pioglitazone affects rat gouty arthritis by regulating cytokines

RHEUMATOLOGY ICD-10 CROSSWALK

Gout in the 21st Century

Inflammation, Rheumatoid Arthritis and Cytokines

Australian Public Assessment Report for Anakinra

Pharmacotherapy of the rheumatoid arthritis. Dr. Erika Pintér 2016

Immune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association

DU maladies systémiques Biothérapies des maladies systémiques Le 25 mai 2012

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Arthritis in Children: Juvenile Rheumatoid Arthritis By Kerry V. Cooke

Evaluation of a Child with Elevated Transaminases. Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Drug Development Services

Historical insights into cytokines

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

CURRICULUM VITAE. NAME: Huang,Po-Hao OFFICE ADDRESS: EDUCATION: EMPLOYMENT RECORD: PROFFESIONAL AFFILIATIONS: 黃 柏 豪

Linköping University Post Print. CARD8 p.c10x polymorphism is associated with inflammatory activity in early rheumatoid arthritis

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

Disorders of Nucleotide Metabolism: Hyperuricemia and Gout

Effector Mechanisms of Humoral Immunity

Rheumatoid Arthritis. Outline. Treatment Goal 4/10/2013. Clinical evaluation New treatment options Future research Discussion

Arthritis and Rheumatology Clinics of Kansas Patient Education. Reactive Arthritis (ReA) / Inflammatory Bowel Disease (IBD) Arthritis

Rheumatoid Arthritis:

Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy

REVIEWS. Averting inflammation by targeting the cytokine environment

This information can also be found in the Summit 2011 Program on page 8.

How To Choose A Biologic Drug

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES `I. Requirements for Prior Authorization of Cytokine and CAM Antagonists

Drug Therapy Guidelines: Humira (adalimumab)

B Cells and Antibodies

Allopurinol Allopurinol

Urinalysis and Body Fluids CRg. Synovial Fluid. Synovial Fluid. Unit 4. Composition and formation. Functions. Reasons for analysis.

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.

T Cell Maturation,Activation and Differentiation

Psoriasis. Psoriasis. Mark A. Bechtel, M.D. Director of Dermatology The Ohio State University College of Medicine

Anti-Inflammatory Drugs from Plant and Marine Sources

Psoriasis and Psoriatic Arthritis Alliance

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

Frenkel et al. Leukocyte activation in HIDS 1. Leukocyte activation in the HyperImmunoglobulinemia D and periodic fever

PATIENT INFORMATION SHEET KEY FACTS

Immune effect of chemotherapies. Francois Ghiringhelli Professor of oncology INSERM U866, Center Georges Francois Leclerc Dijon, France

Immunosuppressive drugs

Chapter 43: The Immune System

Non inflammatory joint diseases

Pipeline: Respiratory, Inflammation & Autoimmunity (RIA) Inhaled therapeutic leadership; spearheading immunology biologics

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Modern Anti-Cytokine Therapy of Autoimmune Diseases

subcutaneous initially every 4 weeks then every 12 weeks Coverage Criteria: Express Scripts, Inc. monograph dated 02/24/2010

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

A New Era in Rheumatoid Arthritis Treatment

3 Rd Year Medical Student Lecture Series. Rheumatology Cases. N. Lawrence Edwards, MD

Once the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.

Lymphoplasmacytic Lymphoma. Hematology fellows conference 4/12/2013 Christina Fitzmaurice, MD, MPH

387

Rheumatoid Arthritis. Nicole Klett,, M.D.

M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.

9/16/2014. Anti-Immunoglobulin E (IgE) Omalizumab (Xolair ) Dosing Guidance

Rheumatoid Arthritis Medicines. A Guide for Adults

Basics of Immunology

Supplemental Material CBE Life Sciences Education. Su et al.

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~

Understanding How Existing and Emerging MS Therapies Work

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Thyroid pathology in the Presence of antiviral treatment of chronic hepatitis C. Professor Nikitin Igor G Russian State Medical University MOSCOW

Critical Issues in School Health Arthritis in the School Setting. Lawrence Zemel MD Tegan Willard RN Connecticut Children s

EMA and Progressive Multifocal Leukoencephalopathy.

INTRAVENOUS IMMUNOGLOBULINS IN THE THERAPY OF IMMUNE-MEDIATED HEMATOLOGIC DISORDERS Susan G. Hackner, BVSc.MRCVS.DACVIM. DACVECC.

Is Monotherapy Treatment of Etanercept Effective Against Plaque Psoriasis?

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

PATIENT MEDICATION INFORMATION

I. INCLUSION AND EXCLUSION CRITERIA

A link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

In vitro co-culture model of the inflamed intestinal mucosa

Rheumatoid arthritis

Overview of Rheumatology

Research in IBD at University of Colorado Denver

Response to Public Comments From the Core Leadership Team for the ACR/SPARTAN/SAA Axial SpA Guideline Development Project July 2013

New Features of PML in the HAART and natalizumab era

Background information

Biologics-Based Therapy for the Treatment of Rheumatoid Arthritis

GOUT REVISITED. The medical management of. Key concepts:

Staph Protein A, Immune Complexes, Cryoglobulins, and the Treatment of Rheumatoid Arthritis:

Transcription:

Autoinflammatory Diseases 26.3.2015 Prof.M.Seitz RIA Department of Rheumatology, Immunology and Allergology

Autoinflammatory disorders Crystal induced joint inflammation Hereditary periodic fever syndromes Cryopyrin-associated syndromes Schnitzler Syndrom M.Behcet? IBD (Crohn, CU)?

Gouty inflammation maximal plasma solubility of MSU 420mmol/l (7mg/ml)

The Inflammasome and gout Martinon et al., JCI 2006

MSU crystals CD14 TLR2/4 MYD88 Urate crystals NFkB mediated cell activation phagocytosis Pro-IL1b NALP3 Caspase 1 caspase-1 ASC IL1b monocyte IL1R endothelial activation Anakinra (Kineret ) Endothelium/leucocyte

The periodic fever syndromes

Characteristics of hereditary periodic fever syndromes Syndrom Symptomatik Gendefekt Therapie FMF Familiäres Mittelmeerfieber Fieber 1-3 Tage, Polyserositis, Arthritis,Erytheme, Splenomegalie, Amyloidose rezessiv, MEFV-Gen, 16p13 pyrin / marenostrin Colchizin NSA Anakinra HIDS Hyper IgD Syndrom Fieber 3-7 Tage Hepatosplenomegalie Bauchschmerz, Exanthem, zervik.lymphadenitis rezessiv, MVK-Gen, 12q24 Mevalonatkinase NSAID Steroide Statine (Simvastatin) Anakinra? TRAPS TNFR-assoziiertes period. Syndrom Fieber > 1 Wo. Bauchschmerzen, Myalgien, Konjunktivitis, Exanthem,Arthralgien, Amyloidose (10%) dominant, TNFRSFIA 12p13 TNFRp55 Steroide Etanercept

Characteristics of hereditary periodic fever syndromes Syndrom Pathogenese Gendefekt Ethnizität/Alter FMF Familiäres Mittelmeerfieber Erhöhte IL-1b Sekretion und NF B- Aktivierung Leukozyten- Apoptose rezessiv, MEFV-Gen, 16p13 pyrin / marenostrin Juden, Armenier, Araber, Türken, Italiener 5 LJ. (50%) 20 LJ. HIDS Hyper IgD Syndrom MK-Aktivität Isoprenoide IL-1b Sekretion rezessiv, MVK-Gen, 12q24 Mevalonatkinase (MK) Holländer, Franzosen, und Nordeuropäer < 1 Jahr TRAPS TNFR-assoziiertes period. Syndrom Ektodomänen-Cleav. und intrazelluläres trafficking von TNFRp55, defekte TNF-induz. Apoptose dominant, TNFRSFIA 12p13 TNFRp55 alle ethnischen Gruppen < 10 Jahre

Characteristics of hereditary periodic fever syndromes Syndrom Symptomatik Gendefekt Therapie FMF Familiäres Mittelmeerfieber Fieber 1-3 Tage, Polyserositis, Arthritis,Erytheme, Splenomegalie, Amyloidose rezessiv, MEFV-Gen, 16p13 pyrin / marenostrin Colchizin NSA Anakinra HIDS Hyper IgD Syndrom Fieber 3-7 Tage Hepatosplenomegalie Bauchschmerz, Exanthem, zervik.lymphadenitis rezessiv, MVK-Gen, 12q24 Mevalonatkinase NSAID Steroide Statine (Simvastatin) Anakinra? TRAPS TNFR-assoziiertes period. Syndrom Fieber > 1 Wo. Bauchschmerzen, Myalgien, Konjunktivitis, Exanthem,Arthralgien, Amyloidose (10%) dominant, TNFRSFIA 12p13 TNFRp55 Steroide Etanercept

Characteristics of hereditary periodic fever syndromes Syndrom Symptomatik Gendefekt Therapie FMF Familiäres Mittelmeerfieber Fieber 1-3 Tage, Polyserositis, Arthritis,Erytheme, Splenomegalie, Amyloidose rezessiv, MEFV-Gen, 16p13 pyrin / marenostrin Colchizin NSA Anakinra HIDS Hyper IgD Syndrom Fieber 3-7 Tage Hepatosplenomegalie Bauchschmerz, Exanthem, zervik.lymphadenitis rezessiv, MVK-Gen, 12q24 Mevalonatkinase NSAID Steroide Statine (Simvastatin) Anakinra? TRAPS TNFR-assoziiertes period. Syndrom Fieber > 1 Wo. Bauchschmerzen, Myalgien, Konjunktivitis, Exanthem,Arthralgien, Amyloidose (10%) dominant, TNFRSFIA 12p13 TNFRp55 Steroide Etanercept

Characteristics of hereditary periodic fever syndromes Syndrom Pathogenese Gendefekt Ethnizität/Alter FMF Familiäres Mittelmeerfieber Erhöhte IL-1b Sekretion und NF B- Aktivierung Leukozyten- Apoptose rezessiv, MEFV-Gen, 16p13 pyrin / marenostrin Juden, Armenier, Araber, Türken, Italiener 5 LJ. (50%) 20 LJ. HIDS Hyper IgD Syndrom MK-Aktivität Isoprenoide IL-1b Sekretion rezessiv, MVK-Gen, 12q24 Mevalonatkinase (MK) Holländer, Franzosen, und Nordeuropäer < 1 Jahr TRAPS TNFR-assoziiertes period. Syndrom Ektodomänen-Cleav. und intrazelluläres trafficking von TNFRp55, defekte TNF-induz. Apoptose dominant, TNFRSFIA 12p13 TNFRp55 alle ethnischen Gruppen < 10 Jahre

Characteristics of cryopyrin-associated autoinflammatory syndromes Syndrom Symptomatik Gendefekt Therapie FCAS Familiäres kälteinduziertes autoinflammat.sy. Fieber < 24h, Arthragien, Konjunktivitis, Kälteinduizierte Urtikaria dominant CIAS1/NALP3/PYAF1 1q44, Cryopyrin Kälte meiden Anakinra Steroide MWS Muckle-Wells Syndrom Fieber 1-2 Tage, Arthralgien, Arthritis, Konjunktivitis sensoneuraler Hörverlust,, Urtikaria, Amyloidose (25%) dominant CIAS1/NALP3/PYAF1 1q44 Cryopyrin Anakinra NOMID/ CINCA Fieber kontinuierlich, aseptische Meningitis, Arthritis, sensoneuraler Hörverlust, Urtikaria, dominant CIAS1/NALP3/PYAF1 1q44 Cryopyrin Anakinra

Characteristics of Cryopyrin - associated autoinflammatory syndromes Syndrom Pathogenese Gendefekt Ethnizität/Alter FCAS Familiäres kälteinduziertes autoinflammat.sy. Erhöhte Aktivität des NALP3/Cryopyrin Inflammasoms mit erhöhter IL-1b Sekretion und NF B Aktivierung dominant CIAS1/NALP3/PYAF1 1q44, Cryopyrin meistens Europäer < 0.5 Jahre MWS Muckle-Wells Syndrom dito dominant CIAS1/NALP3/PYAF1 1q44 Cryopyrin vor allem Nordeuropäer Säugling - bis Schulkindalter NOMID/ CINCA dito dominant CIAS1/NALP3/PYAF1 1q44 Cryopyrin alle ethnischen Gruppen Geburt bis Ende 1.Lebensjahr

Key Messages Autoinflammatory Diseases Autoinflammatory syndromes may be genetically-linked diseases (hereditary periodic fever syndromes) many of which exhibit enhanced NALP3/inflammasome activity) This is also true for crystal-induced arthritis (gout) Autoinflammatory syndromes are mostly IL-1 driven and can successfully be treated with anti-il-1 strategies (i.e. IL-1 receptor antagonist, IL-1β monoclonal antibody)